IMMUNIZATION WITH THE CROSS-REACTIVE ANTIGENS OV39 FROM ONCHOCERCA-VOLVULUS AND HR44 FROM HUMAN RETINAL TISSUE INDUCES OCULAR PATHOLOGY ANDACTIVATES RETINAL MICROGLIA
Nm. Mckechnie et al., IMMUNIZATION WITH THE CROSS-REACTIVE ANTIGENS OV39 FROM ONCHOCERCA-VOLVULUS AND HR44 FROM HUMAN RETINAL TISSUE INDUCES OCULAR PATHOLOGY ANDACTIVATES RETINAL MICROGLIA, The Journal of infectious diseases, 176(5), 1997, pp. 1334-1343
Antigen Ov39, derived from Onchocerca volvulus, cross-reacts on both t
he T and B cell level with a nonhomologous human retinal antigen, hr44
. Lewis rats were immunized to investigate the potential of these anti
gens to induce eye disease. Histologic and immunohistologic examinatio
n of ocular tissues revealed pathologic changes as early as day 12, wh
ich included induction or up-regulation of class II and CD68-like anti
gen on perivascular cells, ramified retinal microglia, dendritiform ce
lls of the iris epithelium, and ciliary epithelium and significant bre
akdown of anterior and posterior blood-ocular barriers. Extravascular
immunoglobulin and staining for CD68-like antigen was detected in the
optic nerve after immunization with Ov39, Unrelated structural abnorma
lities of retina and lens seen in 8% of eyes examined significantly pr
edisposed eyes to the development of Ov39- or hr44-induced pathology.
These findings suggest a role for cross-reactive immune responses in t
he development of ocular onchocerciasis.